keyword
https://read.qxmd.com/read/38607087/mitochondrial-permeability-transition-cell-death-and-neurodegeneration
#1
REVIEW
Artyom Y Baev, Andrey Y Vinokurov, Elena V Potapova, Andrey V Dunaev, Plamena R Angelova, Andrey Y Abramov
Neurodegenerative diseases are chronic conditions occurring when neurons die in specific brain regions that lead to loss of movement or cognitive functions. Despite the progress in understanding the mechanisms of this pathology, currently no cure exists to treat these types of diseases: for some of them the only help is alleviating the associated symptoms. Mitochondrial dysfunction has been shown to be involved in the pathogenesis of most the neurodegenerative disorders. The fast and transient permeability of mitochondria (the mitochondrial permeability transition, mPT) has been shown to be an initial step in the mechanism of apoptotic and necrotic cell death, which acts as a regulator of tissue regeneration for postmitotic neurons as it leads to the irreparable loss of cells and cell function...
April 8, 2024: Cells
https://read.qxmd.com/read/38589016/%C3%AE-synuclein-a-promising-biomarker-for-parkinson-s-disease-and-related-disorders
#2
JOURNAL ARTICLE
Taku Hatano, Ayami Okuzumi, Gen Matsumoto, Tsunemi Taiji, Nobutaka Hattori
Mutations in the SNCA gene, which encodes α-synuclein (α-syn), play a key role in the development of genetic Parkinson's disease (PD). α-Syn is a major component of Lewy bodies in PD and glial cytoplasmic inclusions in multiple system atrophy (MSA). Rapid eye movement sleep behavior disorder (RBD) patients often progress to PD, dementia with Lewy bodies (DLB), or MSA, collectively known as α-synucleinopathies. The loss of dopaminergic neurons with Lewy bodies precedes motor dysfunction in these diseases, but the mechanisms of neurodegeneration due to α-syn aggregation are poorly understood...
April 9, 2024: Journal of Movement Disorders
https://read.qxmd.com/read/38588915/huntington-s-disease-a-clinical-primer-for-acute-and-general-physicians
#3
REVIEW
Thomas H Massey, Duncan J McLauchlan
Huntington's disease (HD) usually manifests in adulthood and is characterised by progressive neurodegeneration in the brain that causes worsening involuntary movements, mental health and cognition over many years. Depression, anxiety and apathy are common. HD is autosomal dominant and affects about 1 in 8,000 people in the UK. There are currently no disease-modifying treatments and so patient care centres on multidisciplinary therapy support and medical treatments to relieve distressing symptoms. Progression of HD is usually slow, and so acute deteriorations often indicate another problem, such as intercurrent infections, constipation, urinary retention, gastro-oesophageal reflux disease or poor dentition...
April 6, 2024: Clinical Medicine: Journal of the Royal College of Physicians of London
https://read.qxmd.com/read/38585782/ablation-of-mitochondrial-rcc1-l-induces-nigral-dopaminergic-neurodegeneration-and-parkinsonian-like-motor-symptoms
#4
Kaylin J Ellioff, Susan M K Osting, Alyssa Lentine, Ashley D Welper, Corinna Burger, Daniel S Greenspan
Mitochondrial dysfunction has been linked to both idiopathic and familial forms of Parkinson's disease (PD). We have previously identified RCC1-like (RCC1L) as a protein of the inner mitochondrial membrane important to mitochondrial fusion. Herein, to test whether deficits in RCC1L mitochondrial function might be involved in PD pathology, we have selectively ablated the Rcc1l gene in the dopaminergic (DA) neurons of mice. A PD-like phenotype resulted that includes progressive movement abnormalities, paralleled by progressive degeneration of the nigrostriatal tract...
March 29, 2024: bioRxiv
https://read.qxmd.com/read/38585363/editorial-movement-disorders-in-neurometabolic-conditions
#5
EDITORIAL
Divyani Garg, Suvasini Sharma, Shekeeb S Mohammad, Asuri Narayan Prasad
No abstract text is available yet for this article.
2024: Frontiers in Neurology
https://read.qxmd.com/read/38582019/clinical-neuroimaging-and-genetic-findings-in-brazilian-patients-with-neurodegeneration-with-brain-iron-accumulation
#6
JOURNAL ARTICLE
Rubens Paulo Araújo Salomão, Flávio Moura Rezende Filho, Vanderci Borges, Manju A Kurian, Henrique Ballalai Ferraz, Guido J Breedveld, Vincenzo Bonifati, Orlando G Barsottini, José Luiz Pedroso
Neurodegeneration with brain iron accumulation (NBIA) encompasses a clinically and genetically heterogeneous group of rare disorders. Here, we report clinical, neuroimaging and genetic studies in twenty three Brazilian NBIA patients. In thirteen subjects, deleterious variants were detected in known NBIA-causing genes (PANK2, PLA2G6, C9ORF12, WDR45 and FA2H), including previously unreported variants in PANK2 and PLA2G6. Two patients carried rare, likely pathogenic variants in genes not previously associated with NBIA: KMT2A c...
March 23, 2024: Parkinsonism & related Disorders
https://read.qxmd.com/read/38581539/mitophagy-upregulation-occurs-early-in-the-neurodegenerative-process-mediated-by-%C3%AE-synuclein
#7
JOURNAL ARTICLE
Sarah Hui, Jimmy George, Minesh Kapadia, Hien Chau, Zahn Bariring, Rebecca Earnshaw, Kashfia Shafiq, Lorraine V Kalia, Suneil K Kalia
Parkinson's disease (PD) is a progressive neurogenerative movement disorder characterized by dopaminergic cell death within the substantia nigra pars compacta (SNpc) due to the aggregation-prone protein α-synuclein. Accumulation of α-synuclein is implicated in mitochondrial dysfunction and disruption of the autophagic turnover of mitochondria, or mitophagy, which is an essential quality control mechanism proposed to preserve mitochondrial fidelity in response to aging and stress. Yet, the precise relationship between α-synuclein accumulation, mitochondrial autophagy, and dopaminergic cell loss remains unresolved...
April 6, 2024: Molecular Neurobiology
https://read.qxmd.com/read/38574438/delayed-levodopa-responsive-parkinsonism-following-acute-midbrain-injury
#8
JOURNAL ARTICLE
Tali Friedman-Korn, Caroline Weill, Simona Ben-Haim, David Arkadir
Acute midbrain injury may cause both hyperkinetic movement disorders and parkinsonism. The temporal interval between the insult and the emergence of hyperkinetic disorders can last years. A delayed appearance of parkinsonism, on the other hand, was rarely described. We present three cases of male patients (50-, 58- and 28-year-old) who developed levodopa-responsive parkinsonism 20, 8 and two years, respectively, after acute brain insult involving the midbrain. Insults included subcortical intracerebral hemorrhage dissecting into the midbrain, embolic basilar occlusion and trauma...
April 1, 2024: Journal of the Neurological Sciences
https://read.qxmd.com/read/38573556/neuroimaging-guided-diagnosis-of-possible-ftld-fus-pathology-a-case-report
#9
JOURNAL ARTICLE
Gregory Mathoux, Cecilia Boccalini, Aurelien Lathuliere, Max Scheffler, Giovanni B Frisoni, Valentina Garibotto
BACKGROUND: This case report presents a patient with progressive memory loss and choreiform movements. CASE PRESENTATION: Neuropsychological tests indicated multi-domain amnestic mild cognitive impairment (aMCI), and neurological examination revealed asymmetrical involuntary hyperkinetic movements. Imaging studies showed severe left-sided atrophy and hypometabolism in the left frontal and temporoparietal cortex. [18 F]Flortaucipir PET exhibited moderately increased tracer uptake in hypometabolic areas...
April 4, 2024: EJNMMI Research
https://read.qxmd.com/read/38561866/dietary-fasting-and-time-restricted-eating-in-huntington-s-disease-therapeutic-potential-and-underlying-mechanisms
#10
REVIEW
Russell G Wells, Lee E Neilson, Andrew W McHill, Amie L Hiller
Huntington's disease (HD) is a devastating neurodegenerative disorder caused by aggregation of the mutant huntingtin (mHTT) protein, resulting from a CAG repeat expansion in the huntingtin gene HTT. HD is characterized by a variety of debilitating symptoms including involuntary movements, cognitive impairment, and psychiatric disturbances. Despite considerable efforts, effective disease-modifying treatments for HD remain elusive, necessitating exploration of novel therapeutic approaches, including lifestyle modifications that could delay symptom onset and disease progression...
April 2, 2024: Translational Neurodegeneration
https://read.qxmd.com/read/38547558/progressive-qtc-prolongation-and-reduced-heart-rate-variability-in-dementia-with-lewy-bodies-compared-to-alzheimer-s-disease
#11
JOURNAL ARTICLE
Mattias Haglund, Isak Heyman, Keivan Javanshiri
INTRODUCTION: Autonomic dysfunction (AuD) is a significant clinical challenge in patients with Dementia with Lewy Bodies (DLB). Manifestations of AuD such as orthostatic hypotension (OH) is associated with falls and decreased quality of life. Cardiac autonomic denervation is an early phenomenon in DLB and a potential contributor to OH. This retrospective study was undertaken to explore whether routine ECG tracings could be used to identify signs of autonomic dysfunction in DLB. METHODS: 18 patients with DLB and 18 age-matched patients with Alzheimer's disease (AD) were included...
March 25, 2024: Parkinsonism & related Disorders
https://read.qxmd.com/read/38521203/the-neurobiological-effects-of-senescence-on-dopaminergic-system-a-comprehensive-review
#12
REVIEW
Gabriel S Rocha, Marco Aurelio M Freire, Karina M Paiva, Rodrigo F Oliveira, Paulo Leonardo A G Morais, José Ronaldo Santos, José Rodolfo L P Cavalcanti
Over time, the body undergoes a natural, multifactorial, and ongoing process named senescence, which induces changes at the molecular, cellular, and micro-anatomical levels in many body systems. The brain, being a highly complex organ, is particularly affected by this process, potentially impairing its numerous functions. The brain relies on chemical messengers known as neurotransmitters to function properly, with dopamine being one of the most crucial. This catecholamine is responsible for a broad range of critical roles in the central nervous system, including movement, learning, cognition, motivation, emotion, reward, hormonal release, memory consolidation, visual performance, sexual drive, modulation of circadian rhythms, and brain development...
March 21, 2024: Journal of Chemical Neuroanatomy
https://read.qxmd.com/read/38507892/the-role-of-peripheral-inflammation-related-biomarkers-in-distinguishing-parkinson-s-disease
#13
JOURNAL ARTICLE
Zhuo Zhang, Yue Wang, Jin Wang, Ying Cai, Peipei Liu, Shoufeng Liu, Jialing Wu, Xin Xie
BACKGROUND: Peripheral inflammation plays a significant role in Parkinson's disease (PD). Conflicting studies on whether inflammatory indicators in blood could serve as biomarkers to distinguish PD. OBJECTIVE: Include a wider range of biomarkers and control confounding factors to comprehensively evaluate the value of peripheral inflammation-related indicators. METHODS: A total of 80 PD patients were recruited and 80 one-to-one matched healthy controls (HCs)...
March 16, 2024: Parkinsonism & related Disorders
https://read.qxmd.com/read/38487476/repetitive-transcranial-magnetic-stimulation-for-major-depressive-disorder-in-huntington-disease-patient-with-improvement-in-neuropsychiatric-and-movement-symptoms-a-case-report
#14
Cheyenne Rahn, Kris Peterson, Elizabeth Lamb
INTRODUCTION: Huntington disease (HD) is a progressive disorder characterized by significant neurodegeneration that results in severe neuropsychiatric symptoms and disordered movement. Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive treatment that has been used in major depressive disorder (MDD) with great success. CASE PRESENTATION: We present a case of a patient with newly diagnosed HD, persistent MDD with suicidal ideation, and generalized anxiety disorder who was treated with rTMS and had sustained significant improvement of her mood disorder with additional improvement of her movement disorder...
2024: Case Reports in Neurology
https://read.qxmd.com/read/38481146/protein-kinase-a-in-neurological-disorders
#15
REVIEW
Alexander G P Glebov-McCloud, Walter S Saide, Marie E Gaine, Stefan Strack
Cyclic adenosine 3', 5' monophosphate (cAMP)-dependent Protein Kinase A (PKA) is a multi-functional serine/threonine kinase that regulates a wide variety of physiological processes including gene transcription, metabolism, and synaptic plasticity. Genomic sequencing studies have identified both germline and somatic variants of the catalytic and regulatory subunits of PKA in patients with metabolic and neurodevelopmental disorders. In this review we discuss the classical cAMP/PKA signaling pathway and the disease phenotypes that result from PKA variants...
March 13, 2024: Journal of Neurodevelopmental Disorders
https://read.qxmd.com/read/38480645/essential-tremor-is-associated-with-reduced-serum-ceruloplasmin-levels
#16
JOURNAL ARTICLE
Xiaotong Hou, Liting Wei, Jinshun Liu, Shibo Li, Jiwei Zhang
BACKGROUND: Essential tremor (ET), a prevalent movement disorder, has an elusive pathogenesis. A reduction in ceruloplasmin (Cp) levels can be found in some patients with ET. In addition, some studies have suggested an association between ET and neurodegeneration. As a ferroxidase, Cp is critical for iron metabolism, protecting against oxidative stress and neurodegeneration. Iron metabolism dysregulation, linked to ferroptosis, has implications in neurodegenerative diseases. Yet, research on Cp and ET remains limited...
March 14, 2024: Neurological Sciences
https://read.qxmd.com/read/38472075/towards-a-biological-diagnosis-of-pd
#17
REVIEW
Avika Chopra, Anthony E Lang, Günter Höglinger, Tiago F Outeiro
Since the original description by James Parkinson, Parkinson's disease (PD) has intrigued us for over 200 years. PD is a progressive condition that is incurable so far, and affects millions of people worldwide. Over the years, our knowledge has expanded tremendously, and a range of criteria have been put forward and used to try to define PD. However, owing to the complexity of the problem, it is still not consensual how to diagnose and classify a disease that manifests with diverse features, and that responds differently to existing therapies and to those under development...
March 6, 2024: Parkinsonism & related Disorders
https://read.qxmd.com/read/38469290/involvement-of-limbic-structures-in-patients-with-isolated-rapid-eye-movement-sleep-behavior-disorder
#18
JOURNAL ARTICLE
D A Lee, H J Lee, K M Park
This study aimed to investigate the alterations in limbic structure volumes and limbic covariance network in patients with isolated rapid eye movement (REM) sleep behavior disorder (iRBD) and to compare them with healthy controls. We retrospectively enrolled 35 patients with iRBD and 35 healthy controls who underwent three-dimensional T1-weighted brain MRI. Volumetric analysis of subcortical limbic structures, including the hippocampus, amygdala, thalamus, mammillary body, hypothalamus, basal forebrain, septal nuclei, fornix, and nucleus accumbens, was performed...
April 2023: Sleep and Biological Rhythms
https://read.qxmd.com/read/38468308/apoe4-genotype-and-aging-impair-injury-induced-microglial-behavior-in-brain-slices-including-toward-a%C3%AE-through-p2ry12
#19
JOURNAL ARTICLE
Jordy Sepulveda, Jennifer Yejean Kim, Joseph Binder, Stefano Vicini, G William Rebeck
Microglia are highly dynamic cells that play a critical role in tissue homeostasis through the surveillance of brain parenchyma and response to cues associated with damage. Aging and APOE4 genotype are the strongest risk factors for Alzheimer's disease (AD), but how they affect microglial dynamics remains unclear. Using ex vivo confocal microscopy, we analyzed microglial dynamic behaviors in the entorhinal cortex (EC) and hippocampus CA1 of 6-, 12-, and 21-month-old mice APOE3 or APOE4 knock-in mice expressing GFP under the CX3CR1 promoter...
March 11, 2024: Molecular Neurodegeneration
https://read.qxmd.com/read/38450553/assessment-of-fitbit-charge-4-for-sleep-stage-and-heart-rate-monitoring-against-polysomnography-and-during-home-monitoring-in-huntington-s-disease
#20
JOURNAL ARTICLE
Emer P Doheny, Klavs Renerts, Andreas Braun, Esther Werth, Christian Baumann, Philipp Baumgartner, Philippa Morgan-Jones, Monica Busse, Madeleine M Lowery, Hans H Jung
STUDY OBJECTIVES: Wearable devices, monitoring sleep stages and heart rate (HR), bring the potential for longitudinal sleep monitoring in patients with neurodegenerative diseases. Sleep quality reduces with disease progression in Huntington's disease (HD). However, the involuntary movements characteristic of HD may affect the accuracy of wrist-worn devices. This study compares sleep stage and heart rate data from the Fitbit Charge 4 (FB) against polysomnography (PSG) in participants with HD...
March 7, 2024: Journal of Clinical Sleep Medicine: JCSM: Official Publication of the American Academy of Sleep Medicine
keyword
keyword
96009
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.